Coherus BioSciences
CHRS
#10164
Rank
โ‚น5.29 B
Marketcap
โ‚น34.27
Share price
-4.47%
Change (1 day)
-67.03%
Change (1 year)

Earnings for Coherus BioSciences (CHRS)

Earnings in 2026 (TTM): -โ‚น13.91 Billion

According to Coherus BioSciences 's latest financial reports the company's current earnings are โ‚น50.93 Million. In 2025 the company made an earning of -โ‚น16.14 Billion, an increase over its 2024 earnings that were of -โ‚น19.08 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Coherus BioSciences from 2014 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น13.91 Billion-13.85%
2025 -โ‚น16.14 Billion-15.4%
2024 -โ‚น19.08 Billion4.1%
2023 -โ‚น18.33 Billion-23.74%
2022 -โ‚น24.03 Billion-1.84%
2021 -โ‚น24.48 Billion-268.38%
2020 โ‚น14.53 B42.13%
2019 โ‚น10.22 B-155.26%
2018 -โ‚น18.51 Billion-12.68%
2017 -โ‚น21.2 Billion90.92%
2016 -โ‚น11.11 Billion-46.49%
2015 -โ‚น20.75 Billion168.87%
2014 -โ‚น7.72 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
โ‚น1.024 T-7,368.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
โ‚น2.84 B-120.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
-โ‚น25.19 Billion 78.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
-โ‚น58.1 Billion 312.28%๐Ÿ‡บ๐Ÿ‡ธ USA